Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VKTX Viking Therapeutics, Inc.

休市中 12-20 15:59:59 EST

42.25

+0.76

+1.83%

盘后42.85

+0.60+1.42%

19:58 EST

最高45.00	最低41.98	成交量883.89万
今开44.03	昨收41.49	日振幅7.29%
总市值47.08亿	流通市值44.56亿	总股本1.11亿
成交额3.82亿	换手率8.38%	流通股本1.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VKTX","market":"US","secType":"STK","nameCN":"Viking Therapeutics, Inc.","latestPrice":42.25,"timestamp":1734728399999,"preClose":41.49,"halted":0,"volume":8838880,"hourTrading":{"tag":"盘后","latestPrice":42.85,"preClose":42.25,"latestTime":"19:58 EST","volume":297215,"amount":12567992.0751,"timestamp":1734742717714},"delay":0,"floatShares":105459203,"shares":111436384,"eps":-0.933775,"marketStatus":"休市中","marketStatusCode":7,"change":0.76,"latestTime":"12-20 15:59:59 EST","open":44.027,"high":45,"low":41.975,"amount":381821107.38528,"amplitude":0.072909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.933775,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1430280000000,"adjPreClose":41.49,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":43.98,"preClose":41.49,"latestTime":"09:29 EST","volume":580137,"amount":26949541.484298,"timestamp":1734704993295},"postHourTrading":{"tag":"盘后","latestPrice":42.85,"preClose":42.25,"latestTime":"19:58 EST","volume":297215,"amount":12567992.0751,"timestamp":1734742717714},"volumeRatio":1.581546095263262,"optionData":{"bulkOrders":[{"symbol":"VKTX","call":true,"expireDate":1740114000000,"strike":"70.0","timestamp":1734711603462,"price":2.049999952316284,"volume":1098,"amount":225090,"type":"-"}]},"impliedVol":1.0718,"impliedVolPercentile":0.6825},"requestUrl":"/m/hq/s/VKTX/wiki","defaultTab":"wiki","newsList":[{"id":"2493270934","title":"BUZZ--美国股票走势-Spire、铜矿商、Abercrombie & Fitch","url":"https://stock-news.laohu8.com/highlight/detail?id=2493270934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493270934?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:41","pubTimestamp":1734720117,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      新闻早报通讯：      12月20日 - 华尔街主要股指周五在震荡交投中跳涨，原因是一份冷于预期的通胀报告缓解了美联储预测2025年仅两次降息引发的一些市场担忧。美国东部时间13:30，道琼斯工业平均指数  上涨1.47%，报42963.15点；标普500指数  上涨1.36%，报5947.02点；纳斯达克综合指数  上涨1.34%，报19632.11点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AADI","AMGN","GPCR","MRK","GALT","LU1934455194.USD","CCL","X","KMX","SOL","SIRI","TQQQ","DOG","DXD","SCCO","QID","HUMA","TSYW.SI","APLM","QLD","USAW.SI","FDX",".IXIC","AVO","NVIW.SI","USJW.SI","DDM","NQmain","MNQmain",".SPX","SQQQ","IONS","SNPS","SR","DJX","NEM","PSQ","ISSC","LU1037948897.HKD","FCX","VKTX","SDOW","LU0719512351.SGD","ALT",".DJI","WGO"],"gpt_icon":1},{"id":"2492440770","title":"BUZZ--美国股票走势-Mission Produce、Sirius XM、嘉年华公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440770?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:39","pubTimestamp":1734709181,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      12月20日 - 标普500指数和纳斯达克指数周五下跌，原因是市场担心明年的高利率问题，尽管一份冷于预期的通胀报告抑制了损失。美国东部时间10:30，道琼斯工业平均指数  上涨0.61%，报42601.62点。标普500指数  上涨0.49%，报5895.94点；纳斯达克综合指数  上涨0.44%，报19457.30点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDS","AADI","WGO","FDX","USJW.SI","SIRI",".SPX","KMX","DNMR","DDM","MNQmain","KUKE","SNPS","IIPR","VKTX","QID",".DJI","IONS","DJX","GALT","AMGN","NVIW.SI","ALT","SQQQ",".IXIC","CCL","XM","SOL","X","TSYW.SI","CLW","NQmain","USAW.SI","GPCR","HUMA","PSQ","SDOW","MRK","TQQQ","APLM","VNCE","DOG","NVO","LLY","QLD","AVO","DXD"],"gpt_icon":1},{"id":"1151227836","title":"诺和诺德跌倒，竞争对手能“吃饱”吗？礼来、安进等股小幅走高","url":"https://stock-news.laohu8.com/highlight/detail?id=1151227836","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151227836?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:14","pubTimestamp":1734707684,"startTime":"0","endTime":"0","summary":"CagriSema减重效果低于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/64d7f8b1a0687a6bf124201afc1b1baa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德跌倒，竞争对手能“吃饱”吗？礼来、安进等股周五齐涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LLY","VKTX","AMGN"],"gpt_icon":0},{"id":"2492449584","title":"BUZZ--美国股票走势-Humacyte、Ionis 制药公司、Emeren 集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2492449584","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492449584?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:12","pubTimestamp":1734703974,"startTime":"0","endTime":"0","summary":"** 联邦快递FDX.N:BUZZ - 分析师认为联邦快递分拆货运部门是有益的；将PT升至 nL4N3NL0I5 。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGO","LU0348723411.USD","IE00BJLML261.HKD","LU0094547139.USD","LU1878469433.USD","IE00B4R5TH58.HKD","X","LU0096364046.USD","LU2238339852.HKD","LU2458330169.SGD","GALT","LU0823416689.USD","LU2357305700.SGD","BK4555","LLY","LU1988902786.USD","LU0109392836.USD","LU2361044949.HKD","LU0157215616.USD","SOL","ALT","LU1429558221.USD","BK4133","SG9999015978.USD","LU0957791311.USD","LU1280957306.USD","LU0820561818.USD","LU1914381329.SGD","IONS","LU0256863902.USD","KMX","AADI","APLM","SGXZ81514606.USD","TSYW.SI","LU0310800965.SGD","AMPS","LU0466842654.USD","AMGN","SNPS","ANSS","GPCR","FDX","LU0114720955.EUR","VKTX","HUMA","SG9999015986.USD","LU0061475181.USD","LU2458330243.SGD"],"gpt_icon":1},{"id":"2492414611","title":"BUZZ--美国股票走势-联邦快递、礼来公司、Aadi 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492414611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492414611?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:04","pubTimestamp":1734696255,"startTime":"0","endTime":"0","summary":"** 联邦快递  ： BUZZ - 分析师认为联邦快递分拆货运卡车部门是有益的；上调PT   ** Eli Lilly and Co   : BUZZ - 诺和诺德的下一代肥胖症药物在研究中表现不佳，导致价格上涨   ** Humacyte   : BUZZ - 因血管植入物获得 FDA 批准而上涨逾 40   ** 美国钢铁  : BUZZ - 在预测第四季度意外亏损后下跌   ** Aadi Bioscience   : BUZZ - 因癌症药物许可协议而上涨   ** Viking Therapeutics   ：** Structure Therapeutics   ：** Altimmune   ：** 安进  ： BUZZ - 诺和诺德的肥胖症药物在研究中表现不佳，减肥药开发商获得收益   ** Ionis Pharmaceuticals   : BUZZ - 因FDA批准遗传性疾病药物而上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","BK4588","LU0354030438.USD","SG9999017495.SGD","IE00B1BXHZ80.USD","LU0466842654.USD","LU1551013425.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","SG9999018857.SGD","BK4520","LU1061106388.HKD","LU1878469433.USD","AADI","SG9999001440.SGD","LU2265009873.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0114720955.EUR","BK4585","LU0122379950.USD","LU2602419157.SGD","LU0079474960.USD","GPCR","AMGN","LU0058720904.USD","LU1064131342.USD","BK4599","X","LU0310800965.SGD","LU0820561909.HKD","LU0742534661.SGD","LU2089984988.USD","FDX","ALT","LU0238689110.USD","LU0471298694.HKD","LU1035775433.USD","IONS","LU1988902786.USD","LU0354030511.USD","LU1868836591.USD","BK4006","LU1868837300.USD","LU2360106947.USD","LU0882574139.USD","LU1093756325.SGD","LU0320765992.SGD","VKTX","LLY"],"gpt_icon":1},{"id":"1119274875","title":"异动解读 | 竞争对手新药失利 Viking Therapeutics盘前大涨20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119274875","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119274875?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:44","pubTimestamp":1734695055,"startTime":"0","endTime":"0","summary":"据报道,盘前市场上Viking Therapeutics, Inc.(VKTX)股票大涨20.41%,引发投资者广泛关注。\n\n导致VKTX股价暴涨的主要原因,是该公司的竞争对手诺和诺德公司旗下新型肥胖症药物CagriSema在后期临床试验中的减重效果未达预期。诺和诺德公布,该药物仅能帮助超重患者减轻22.7%的体重,低于预期的25%。\n\n作为肥胖症药物的开发商,VKTX等公司的竞争力因此提高,前景获得提振。投资者对这些公司未来的增长潜力更有信心,因而推升了VKTX等相关股票的股价。但诺和诺德在美国的股票盘前暴跌22.4%,与其主要竞争对手礼来公司的Wegovy药物的成功形成鲜明对比。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 竞争对手新药失利 Viking Therapeutics盘前大涨20%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VKTX"],"gpt_icon":0},{"id":"2492241903","title":"BUZZ-诺和诺德肥胖症药物在研究中表现不佳，减肥药开发商获益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2492241903","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492241903?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:40","pubTimestamp":1734694859,"startTime":"0","endTime":"0","summary":"    12月20日 - ** 诺和诺德公司的  下一代肥胖症实验药物在后期试验中的减重效果低于预期，一些减肥药开发商的股票在盘前上涨** 诺和诺德称其药物CagriSema帮助超重患者减轻了22.7%的体重 ，低于其25%的预期。** 诺和诺德在美国上市的股票下跌 22.4%，而竞争对手礼来  上涨 10** 投资者和分析师热切期待着这一数据，以检验诺和诺德是否拥有强大的药物管线，在竞争激烈的抗肥胖症市场上紧随Wegovy之后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4de5f7200a34a5a69d5dce1d967bfe14","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5M84.HKD","LU0203202063.USD","LU0354030438.USD","LU1868836757.USD","LU1093756168.USD","LU1712237335.SGD","LU2237438978.USD","LU0096364046.USD","LU1814569148.SGD","IE00BJT1NW94.SGD","LU0198837287.USD","LU1804176565.USD","LU1551013342.USD","SGXZ57979304.SGD","LU0820561818.USD","LU1878469433.USD","LU0943347566.SGD","LU0640476718.USD","LU1291159041.SGD","LU0109391861.USD","LU2237443978.SGD","LU1868836914.USD","LU0385154629.USD","LU1983299246.USD","IE00BZ1G4Q59.USD","GPCR","LU0689472784.USD","AMGN","LU2242652126.USD","IE00BJJMRZ35.SGD","SG9999014898.SGD","IE00BKVL7J92.USD","LU0820561909.HKD","LU1623119135.USD","LU0471298777.SGD","LU2089984988.USD","LU2264538146.SGD","ALT","LU2461242641.AUD","LU2491050154.USD","LU2361044865.SGD","NVO","SG9999001176.SGD","LU0320765059.SGD","SG9999014906.USD","LU0882574139.USD","LU1571399168.USD","VKTX","LLY","LU0256863811.USD"],"gpt_icon":1},{"id":"2492799101","title":"Viking Therapeutics, Inc.盘中异动 早盘股价大涨5.02%报40.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492799101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492799101?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:33","pubTimestamp":1734618806,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时33分，Viking Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.87%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。公司临床方案管线包括VK2809、VK5211、VK0214产品。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922333695ea7aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922333695ea7aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VKTX","BK4599","BK4139","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"2492518003","title":"BUZZ--美国股票走势-美国电池技术公司、奥利廉价直销店、BioAge 实验室","url":"https://stock-news.laohu8.com/highlight/detail?id=2492518003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492518003?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:49","pubTimestamp":1734536958,"startTime":"0","endTime":"0","summary":"标普500指数  上涨0.17%，报6,060.78点；纳斯达克综合指数  上涨0.15%，报20,139.86点。** Cognition Therapeutics   : BUZZ - 因痴呆症药物在中期试验中达到主要目标而上涨   ** 通用磨坊  : BUZZ - 因下调年度利润预期而下跌   ** Oklo   : BUZZ - 因与人工智能公司斯维奇达成部署12吉瓦核电的协议而上涨   ** 捷普  : BUZZ - 因第一季度业绩超预期而上涨   ** Inotiv   : BUZZ - 因股票发行定价而下跌   ** Xometry   : BUZZ - 摩根大通将 Xometry 的评级提升至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABAT","MU","PKG","VKTX","YY","IVV","NVDS.UK","BIOA","BIRK","OEX","COMM","GPCR","2NVD.UK",".IXIC","JBL","NOTV","UPRO","AAPL","NVDA","NVDX","OLLI","SNVD.UK",".SPX","DXD","NVDS","ACHR","DOG","SH","NVD","ESmain","DDM","MTCH",".DJI","3NVD.UK","NVIW.SI","NVDU","MYPS","ANGI","SSO","SPXU","XMTR","NVD2.UK","SDS","DJX","SDOW","GETY","GIS","SPY","CGTX"],"gpt_icon":1},{"id":"2492816261","title":"Viking Therapeutics, Inc.盘中异动 早盘急速跳水8.77%报42.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492816261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492816261?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:33","pubTimestamp":1734532386,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时33分，Viking Therapeutics, Inc.股票出现波动，股价急速下跌8.77%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1012.18%、300.82%、241.07%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为66.83%、37.37%、24.76%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223313a1f8c257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223313a1f8c257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4585","BK4139","LENZ","VKTX","BK4588"],"gpt_icon":0},{"id":"2492787189","title":"BUZZ-默克公司签署 20 亿美元开发肥胖症口服药协议后，部分肥胖症药物开发商股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2492787189","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492787189?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:28","pubTimestamp":1734532124,"startTime":"0","endTime":"0","summary":"12月18日 -  ** 肥胖症药物开发商Structure Therapeutics GPCR.O和Viking Therapeutics VKTX.O的股价在盘前交易中下跌7%至8  ** GPCR 下跌 7.2%，报 29.20 美元；VKTX 下跌 8.3%，报 42.80 美元 ** 默克MRK.N与汉寿制药3692.HK在 ，以开发和销售这家中国生物技术公司的实验性口服肥胖症药物。** 截至上次收盘，GPCR 下跌 22.8%，而 VKTX 则累计上涨 150.9 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4T3NJ11L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU1551013342.USD","IE00BJLML261.HKD","LU0203201768.USD","LU0354030438.USD","LU0672654240.SGD","SG9999002232.USD","BK4139","LU0354030511.USD","LU0203202063.USD","PFE","LU1623119135.USD","LU1571399168.USD","LU1868837300.USD","LU0320765489.SGD","LLY","SG9999018857.SGD","BK4007","LU0965508806.USD","LU0225771236.USD","LU0265550359.USD","LU0238689110.USD","01638","03692","LU1037948897.HKD","LU1066051225.USD","SG9999001176.USD","SGXZ57979304.SGD","LU1057294990.SGD","LU1069344957.HKD","SG9999003800.SGD","LU2237443382.USD","LU2265009873.SGD","BK1191","LU1989772840.SGD","LU0321505439.SGD","SG9999014567.USD","LU1585245621.USD","GPCR","IE00BLSP4239.USD","LU0861579265.USD","LU0114720955.EUR","VKTX","LU0198837287.USD","LU2361044865.SGD","MRK","LU1127390331.HKD","IE00B2B36J28.USD","LU0306807586.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2490043339","title":"Viking Therapeutics, Inc.盘中异动 急速下挫5.05%报47.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490043339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490043339?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:33","pubTimestamp":1733848431,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时33分，Viking Therapeutics, Inc.股票出现波动，股价大幅下挫5.05%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1949.79%、459.44%、155.84%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Jupiter Neurosciences, Inc.，振幅分别为154.91%、131.78%、121.49%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211003351ab6d2c82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211003351ab6d2c82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","VKTX","LENZ","BK4588","BK4599"],"gpt_icon":0},{"id":"2486865754","title":"减肥药或纳入美国医保，特朗普团队成最强“拦路虎”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2486865754","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486865754?lang=zh_cn&edition=full","pubTime":"2024-11-27 09:45","pubTimestamp":1732671925,"startTime":"0","endTime":"0","summary":"“减肥双雄”领衔大涨","market":"hk","thumbnail":"https://img3.gelonghui.com/a4f91-2de5eac7-c0e3-4125-a2d7-96fbc20d5957.jpg?guru_height=759&guru_width=1216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a4f91-2de5eac7-c0e3-4125-a2d7-96fbc20d5957.jpg?guru_height=759&guru_width=1216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1388180","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0289739699.SGD","LU0094547139.USD","LU1868837300.USD","SGXZ51526630.SGD","LU0198837287.USD","LU1623119135.USD","BK4139","LU0079474960.USD","LU2112291526.USD","LU0320765059.SGD","SG9999014898.SGD","LU0882574139.USD","SGXZ57979304.SGD","LU1804176565.USD","LU1035775433.USD","SG9999018865.SGD","LU1974910355.USD","LU0820561909.HKD","LU2237443382.USD","VKTX","LU2106854487.HKD","SG9999015945.SGD","LU2361044865.SGD","LU0882574055.USD","SG9999015978.USD","SGXZ81514606.USD","LU1814569148.SGD","LU1093756325.SGD","LU0256863902.USD","LU2491049909.HKD","IE00B4R5TH58.HKD","HHS","LU2361045086.USD","LU1267930730.SGD","LU2237443549.SGD","SGXZ31699556.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU0203201768.USD","BK4585","LU0096364046.USD","SG9999001176.USD","NVO","LU2491050071.SGD","LU2324357040.USD","LU1551013425.SGD","LU0114720955.EUR","LLY","LU0238689110.USD","LU0109391861.USD"],"gpt_icon":1},{"id":"2486087887","title":"嗡嗡声--美国股票走势-高盛, Zoom, Rumble","url":"https://stock-news.laohu8.com/highlight/detail?id=2486087887","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486087887?lang=zh_cn&edition=full","pubTime":"2024-11-27 02:47","pubTimestamp":1732646870,"startTime":"0","endTime":"0","summary":"[.N美国东部时间13:30，道琼斯工业平均指数.DJI下跌0.05%，报44,713.15点；标准普尔500指数.SPX上涨0.38%，报6,010.24点；纳斯达克综合指数.IXIC上涨0.48%，报19,145.57点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** NRG Energy Inc NRG.N，上涨 9.1. ** 星座能源公司CEG.OQ，上涨5.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX1L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","LU2242646821.SGD","AMGN","IE00BFTCPJ56.SGD","REPL","WWD","RUM","CRC","SCCO","UAL","ASPI","MAC","PINS","ALK","LU1066051498.USD","MAXN","DAL","MARA","EXAS","DKS","OVV","CVX","CPRI","ATRO","HUT","LU0310800965.SGD","LU0689472784.USD","VKTX","LU0278409577.USD","LU2023250504.SGD","COIN","AMWD","LU0203201768.USD","TOYO","GS","ALEC","SLNO","JBLU","SMTC","RIOT","APA","LU0050427557.USD","LU1988902786.USD","FCX","ARWR","DVN","SJM"],"gpt_icon":1},{"id":"2486888162","title":"BUZZ-竞争对手安进公司的数据不尽如人意，减肥药生产商业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2486888162","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486888162?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:05","pubTimestamp":1732637103,"startTime":"0","endTime":"0","summary":"** 包括本交易日的涨幅在内，LLY 的涨幅 约为35%，VKTX 的年度涨幅超过 三倍。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX1F6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU2461242641.AUD","VKTX","LU1093756325.SGD","BK4139","LU2468319806.SGD","IE00BJLML261.HKD","LU1814569148.SGD","LU0640476718.USD","LU1551013342.USD","LU1868836757.USD","SG9999013999.USD","LU0385154629.USD","IE0004445239.USD","IE0002141913.USD","BK4533","LU0006306889.USD","LLY","LU0096364046.USD","LU2265009873.SGD","AMGN","SG9999015945.SGD","LU1366192091.USD","SG9999015978.USD","LU1868837300.USD","LU0320765059.SGD","LU1069344957.HKD","LU2361044949.HKD","LU0256863811.USD","LU2237443895.HKD","LU2063271972.USD","LU0672654240.SGD","LU2023250504.SGD","IE00BJT1NW94.SGD","LU2237443978.SGD","LU0114720955.EUR","LU0882574055.USD","LU1983299246.USD","LU0354030438.USD","SG9999017495.SGD","LU0198837287.USD","SG9999015952.SGD","SG9999014880.SGD","LU0354030511.USD","LU1623119135.USD","LU0109394709.USD","LU2106854487.HKD","IE0009355771.USD","BK4007","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2486000091","title":"嗡嗡声--美国股票走势-Pinterest、百思买、雪佛龙","url":"https://stock-news.laohu8.com/highlight/detail?id=2486000091","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486000091?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:53","pubTimestamp":1732636408,"startTime":"0","endTime":"0","summary":"** Astronics Corp   : BUZZ - 因发行 1.5 亿美元可转换债券而下跌    ** Soleno Therapeutics Inc   : BUZZ - 因FDA延长对遗传性疾病药物的审查而下跌   ** Arrowhead Pharmaceuticals Inc   : BUZZ - 与 Sarepta 达成许可协议后跳涨    ** 帝国石油公司   ：** Suncor Energy Inc   ：** Canadian Natural Resources Ltd   : BUZZ - 加拿大石油公司在特朗普誓言征收新关税后下跌    ** Capri Holdings Ltd   :","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","ALEC","RUM","DKS","MAC","VKTX","ONB","SLNO","SQQQ","SMTC","ADI","F","ATRO","LLY","UDOW","AMWD",".IXIC","BBY","DXD","CRC","AMGN","DJX","EG",".DJI","HUT","WH","LDOS","GM","H","EXAS","ASPI","QID","CVX","MAXN","WWD","KSS","PSQ","QLD","REPL","ARWR","PINS","PSTX","CPRI","SJM"],"gpt_icon":1},{"id":"2486217001","title":"Viking Therapeutics, Inc.盘中异动 早盘快速上涨6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486217001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486217001?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:31","pubTimestamp":1732631469,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时31分，Viking Therapeutics, Inc.股票出现波动，股价快速拉升6.38%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.、Fate Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Citius Pharmaceuticals, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为13.01%、9.59%、9.52%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Bioline Rx Ltd、Fate Therapeutics, Inc.，振幅分别为10.91%、8.17%、7.85%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223109a25744bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223109a25744bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LENZ","VKTX","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2486069260","title":"嗡嗡声--美国股票走势-Rivian、富国银行、Woodward","url":"https://stock-news.laohu8.com/highlight/detail?id=2486069260","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486069260?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:20","pubTimestamp":1732630816,"startTime":"0","endTime":"0","summary":".N  ** Poseida Therapeutics Inc PSTX.O:BUZZ - 因罗氏公司15亿美元的收购而上涨三倍多 nL3N3MX0RD  ** Rivian Automotive Inc RIVN.O:BUZZ - 在获得 66 亿美元贷款以建设佐治亚州电动汽车工厂后上涨 nL3N3MX0QP  ** Kohl's Corp KSS.N:BUZZ - 在预测年度销售额将出现更大跌幅后下跌 nL3N3MX0X8. ** Hut 8 Mining Corp HUT.O：BUZZ - 加密股票因比特币疲软而下跌 nL3N3MX0WF  ** Zoom Video Communications Inc ZM.O:BUZZ - 股价下滑，原因是第三季度超预期增长后可能出现获利回吐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3T3MX17D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADI","F","WH","CVX","LU0238689110.USD","ONB","AMGN","REPL","BK4551","MAXN","SG9999017495.SGD","WFC","EXAS","BK4525","EG","LU0648001328.SGD","SG9999014880.SGD","BK4599","LDOS","ALEC","LU1496350502.SGD","PSTX","H","SG9999018857.SGD","KSS","BK4566","RIVN","HUT","LU1623119135.USD","AMWD","GM","BBY","BK4570","LU0320765059.SGD","LU1162221912.USD","RUM","VKTX","CRC","SJM","LU1861558580.USD","SMTC","DKS","WWD","LU1280957306.USD","MAC"],"gpt_icon":1},{"id":"1124619953","title":"异动解读 | 安健公司减肥药试验失利,Viking Therapeutics股价盘前大涨10.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124619953","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124619953?lang=zh_cn&edition=full","pubTime":"2024-11-26 21:48","pubTimestamp":1732628901,"startTime":"0","endTime":"0","summary":"根据消息,Viking Therapeutics公司(股票代码:VKTX)在盘前交易中股价大涨10.61%,引发市场关注。\n\n造成VKTX股价大涨的主要原因是,它的竞争对手安健公司近期公布了一项实验性减肥药MariTide的临床试验结果。该试验结果显示,经过治疗,患者平均体重只减轻了20%,远低于投资者的预期。\n\n与此同时,VKTX和礼来公司正在研发的其他减肥药物则取得了不错的临床表现。礼来的注射减肥药Zepbound在一项为期72周的试验中,帮助患者平均减重超过22%。VKTX的候选药物VK2735在今年早些时候的一项中期研究中,也帮助患者平均减轻近15%的体重。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 安健公司减肥药试验失利,Viking Therapeutics股价盘前大涨10.61%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VKTX"],"gpt_icon":0},{"id":"2486003584","title":"BUZZ-竞争对手安进公司数据不佳，减肥药开发商获益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2486003584","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486003584?lang=zh_cn&edition=full","pubTime":"2024-11-26 21:44","pubTimestamp":1732628695,"startTime":"0","endTime":"0","summary":"11月26日 -  ** 肥胖症药物开发商礼来LLY.N股价 盘前上涨~5%，同行 Viking TherapeuticsVKTX.O上涨~8%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3T3MX15B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2602419157.SGD","LU2237438978.USD","LU2023250504.SGD","LU0114720955.EUR","LU1061106388.HKD","SG9999013999.USD","LU0882574055.USD","LU0256863811.USD","LU0094547139.USD","LU0058720904.USD","LU1551013342.USD","LU1093756168.USD","LU0238689110.USD","IE00BJT1NW94.SGD","IE0004445239.USD","BK4534","LU0354030511.USD","LU2360106947.USD","LU0471298777.SGD","LU0466842654.USD","LU2237443465.HKD","LU0417517546.SGD","BK4588","LU0689472784.USD","LU2361044865.SGD","LU1267930730.SGD","SGXZ31699556.SGD","LU2211815571.USD","SG9999015945.SGD","LU0456855351.SGD","LLY","LU1035775433.USD","BK4581","LU1069344957.HKD","LU0198837287.USD","LU1804176565.USD","LU2237443978.SGD","AMGN","LU1814569148.SGD","LU1868837136.USD","LU0889565916.HKD","SGXZ57979304.SGD","LU1093756325.SGD","LU1064131342.USD","LU2112291526.USD","LU0096364046.USD","LU0289739699.SGD","VKTX","SG9999014880.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.vikingtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1016},{"period":"1month","weight":-0.1801},{"period":"3month","weight":-0.4005},{"period":"6month","weight":-0.1989},{"period":"1year","weight":1.3459},{"period":"ytd","weight":1.2703}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viking Therapeutics, Inc.于2012年9月24号在特拉华州成立。该公司是一个临床阶段的生物制药公司，致力于开发新的，第一类或最好的新陈代谢和内分泌失调类疗法。该公司拥有全球独家权利基于许可的配体小分子组合在五个候选药物在临床试验或临床前研究。公司的主导临床程序是VK0612，它是进入2b期临床试验为2型全球最大的健康挑战之一的治疗糖尿病疾病口服药物，它在同药物中排列第一。公司的第二临床程序vk5211，可把口服的候选药物送入第二阶段临床试验治疗一种复杂的疾病特点的不受控制的肌肉质量下降癌症恶病。VK5211是一种非甾体选择性雄激素受体调节剂，或SARM。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.031825},{"month":2,"riseRate":0.555556,"avgChangeRate":0.264573},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020024},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000523},{"month":5,"riseRate":0.3,"avgChangeRate":0.094367},{"month":6,"riseRate":0.4,"avgChangeRate":-0.023196},{"month":7,"riseRate":0.5,"avgChangeRate":-0.005074},{"month":8,"riseRate":0.5,"avgChangeRate":0.030421},{"month":9,"riseRate":0.3,"avgChangeRate":0.062199},{"month":10,"riseRate":0.3,"avgChangeRate":0.012685},{"month":11,"riseRate":0.5,"avgChangeRate":-0.01667},{"month":12,"riseRate":0.6,"avgChangeRate":0.166007}],"exchange":"NASDAQ","name":"Viking Therapeutics, Inc.","nameEN":"Viking Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viking Therapeutics, Inc.(VKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viking Therapeutics, Inc.,VKTX,Viking Therapeutics, Inc.股票,Viking Therapeutics, Inc.股票老虎,Viking Therapeutics, Inc.股票老虎国际,Viking Therapeutics, Inc.行情,Viking Therapeutics, Inc.股票行情,Viking Therapeutics, Inc.股价,Viking Therapeutics, Inc.股市,Viking Therapeutics, Inc.股票价格,Viking Therapeutics, Inc.股票交易,Viking Therapeutics, Inc.股票购买,Viking Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viking Therapeutics, Inc.(VKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况